MiraDx

MiraDx builds genetic tests to predict patient responses to cancer treatments. We have also developed an FDA-authorized COVID-19 test. My name is Joanne Weidhaas, and I am an oncologist, molecular biologist and professor at UCLA. I founded MiraDx in 2008 with my colleague Frank Slack. MiraDx spun out of our research on a new class of genetic biomarkers. Over the last year, in addition to developing a COVID-19 test in the lab, we have also developed software to handle our large volume of COVID-19 testing. We are looking for our first full-time software engineering hire to take the lead on that software (our stack is TypeScript, Next.js/React, Salesforce). Longer term, you would lead the development of new software to streamline our genetic testing more broadly. You would also take significant product ownership of the software roadmap. If you're interested, please email me at joanne@miradx.com with "Software Engineer HN" in the subject line.